Today: 3 March 2026
Subscribe
Browse Category

Stock Market 16 October 2025

HPE Stock Soars and Dips: Inside Hewlett Packard Enterprise’s Wild October Ride

HPE Stock Soars and Dips: Inside Hewlett Packard Enterprise’s Wild October Ride

Hewlett Packard Enterprise shares fell 5–7% after hours on Oct. 15 following cautious FY2026 guidance, despite a recent 52-week high of $26.44 and a 16% year-to-date gain. The company announced a 10% dividend increase and $3 billion in new buybacks at its analyst meeting. Q3 revenue rose 19% to $9.14 billion, but EPS missed forecasts. HPE’s AI tech was recently licensed by Nokia for telecom automation.
16 October 2025
·
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre shares fell about 5% to $2,048 on Oct. 15, 2025, after peaking near $2,500 last month. Q2 revenue beat forecasts at $6.8 billion, but net income missed due to heavy spending in Brazil. The company launched a B2B marketplace and entered Brazil’s pharmacy sector. MercadoPago’s credit portfolio nearly doubled year-over-year to $9.3 billion, with active fintech users up 30%.
16 October 2025
··
iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

iRobot Stock Skyrockets 55% in Short-Squeeze Frenzy – Bubble or Breakout?

iRobot shares surged 36% on Oct. 15, closing at $5.37 after hitting $6.09, the highest in seven months. Trading volume topped 7 million shares amid a short squeeze, with short interest at 26–28% of float. The rally came despite no major news and ongoing financial struggles, including falling revenue and warnings about the company’s future. iRobot is reviewing strategic options after the failed Amazon takeover.
16 October 2025
··
Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Sana Biotechnology shares jumped 26% to $5.62 on Oct. 15 after hedge fund manager Eric Jackson called the stock a potential “100-bagger” on X, triggering volatility halts. The rally followed early trial results showing transplanted pancreatic cells produced insulin without immunosuppressive drugs. Sana raised $105 million in summer 2025, extending its cash runway into late 2026. Analyst ratings remain mixed, with targets ranging from $5 to $12.
16 October 2025
··
Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

CRML shares soared 62% on Oct. 6 after Reuters reported U.S. talks to buy a stake in its Greenland rare-earth project. The stock hit a 52-week high near $32 in mid-October before plunging 24% to $22.72 on Oct. 15, then rebounding to the mid-$20s. Trading volume topped 60 million shares on Oct. 14 amid surging retail interest. Analyst ratings remain mixed, with some warning of overvaluation.
16 October 2025
·
Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune Therapeutics shares surged 42% on October 8, 2025, after nearly doubling intraday on September 19, despite no major news and record trading volumes. The company sold its key T-cell therapy programs, including Tecelra, to US WorldMeds for $55 million upfront to pay off debt and avoid insolvency. Q2 net loss reached $30.3 million, with cash reserves at $26 million by mid-year. Analysts remain bearish, with no major buy ratings.
16 October 2025
··
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Stocks Surge on Trade Optimism and Fed Cut Hopes – Is a New Bull Run Brewing?

The S&P 500 closed near 6,671, up 0.4%, and the Nasdaq reached 22,670, up 0.7%, as trade-war concerns eased and Fed officials signaled more rate cuts. Morgan Stanley rose 4.7% and Bank of America 4.4%. AMD spiked about 24% in a day; Nvidia is up 41% year-to-date. Dow futures rose 0.4% and S&P 500 futures 0.2% on the morning of Oct. 16.
16 October 2025
········
Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi & Warren Buffett Are Both Betting on These 4 Stocks — What Do They Know?

Nancy Pelosi, via her husband’s trades, and Warren Buffett’s Berkshire Hathaway both hold Amazon, Apple, Visa, and American Express. As of mid-October 2025, Apple trades near $250 and Amazon at $215–$216. Pelosi’s Tempus AI bet surged to $92, up 185% since January. Pelosi’s portfolio returned 693% since 2014, more than double Buffett’s 304%, but fell 7.4% in the last year.
16 October 2025
····
Apple Unleashes M5 Chip: The AI Powerhouse – Will AAPL Stock Soar?

Apple Unleashes M5 Chip: The AI Powerhouse – Will AAPL Stock Soar?

Apple unveiled its new M5 chip on Oct. 15, powering updated 14-inch MacBook Pro, iPad Pro, and Vision Pro headset models. All three devices are available for pre-order now and ship Oct. 22, with prices unchanged: MacBook Pro from $1,599, iPad Pro from $999, Vision Pro at $3,499. Apple claims the M5 delivers four times the AI GPU performance of the M4. Shares rose 0.6% after the announcement.
16 October 2025
···
SpaceX’s Starship Launch Sends Space Stocks Soaring – Historic Test Closes Block 2 Chapter

SpaceX’s Starship Launch Sends Space Stocks Soaring – Historic Test Closes Block 2 Chapter

SpaceX’s Starship completed its final Block 2 test flight on Oct. 13, 2025, launching from Texas and deploying eight dummy Starlink satellites. The Super Heavy booster splashed down in the Gulf of Mexico; the upper stage landed near Australia. SpaceX will now shift to building Version 3 Starship for lunar and Mars missions. Space-related stocks rose 4–6% on the news.
16 October 2025
·······
Powell’s High-Stakes Speech Spurs Markets – Fed Signals More Rate Cuts in 2025

Fed Cuts Rates — But Mortgage Rates Refuse to Fall, Tech Stocks Surge to New Highs

The Federal Reserve cut its benchmark rate by 25 basis points in September and signaled two more cuts this year, but 30-year mortgage rates remain near 6.2%. Pending home sales fell 1.3% year-over-year in September as buyers wait for lower rates. The 10-year Treasury yield hovers around 4.0%, driven by surging federal debt. Meanwhile, the S&P 500 and Nasdaq reached record highs in early October, led by tech and AI stocks.
16 October 2025
·····
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Skyrockets 75% on $40M Oil Deal – Bulls and Bears Debate What’s Next

Vivakor shares jumped nearly 75% on October 15, 2025, after announcing a $40 million oil trading credit facility. Trading volume topped 230 million shares, with the price closing at $0.28, up from $0.19 the day before. The company also received a Nasdaq compliance extension to March 2026 and postponed a special dividend to October 31. Vivakor remains under $10 million in market value and posted a $23 million net loss for 2024.
16 October 2025
··
NIO Stock Rollercoaster: Record EV Sales, Lawsuit Shock, and What’s Next for the Tesla Rival

NIO Stock Rollercoaster: Record EV Sales, Lawsuit Shock, and What’s Next for the Tesla Rival

NIO delivered a record 87,071 vehicles in Q3 2025, up 40.8% year-on-year, lifting its stock to $7.70 in early October. On Oct. 16, Singapore’s GIC sued NIO for allegedly inflating $600 million in revenue, triggering a 10% intraday stock plunge to $6.30. Shares remain about 50% higher than at the start of 2025. Investor sentiment is split amid ongoing losses, a fraud lawsuit, and fierce competition.
16 October 2025
···
Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Sea Limited Stock’s Wild Ride: SE Surges 300% Then Plunges – What’s Next for Shopee’s Tech Giant?

Sea Limited shares fell 9.6% to $163.42 on Oct. 15, 2025, after a sharp rally that brought the stock near its 52-week high. Q2 revenue rose 38.2% to $5.26 billion, with all three core units reporting strong growth. Shopee remains profitable and expanding, while Garena’s Free Fire saw an 18% jump in paying users. Competition from Lazada, TikTok Shop, and new Indonesian taxes pose headwinds.
16 October 2025
···
Microvast Stock Skyrockets 19% on $125M Equity Raise & Battery Breakthroughs

Microvast (MVST) Stock Hits New High on Battery Breakthroughs and $125 M Funding – What’s Next?

Microvast Holdings (NASDAQ: MVST) hit a 52-week high of $6.42 on Oct. 16, up 119% year-to-date and over 2,600% from last year’s lows. The EV battery maker reported record Q2 revenue of $91.3 million and positive adjusted EBITDA, but remains unprofitable. Microvast raised up to $125 million in an equity offering this month. Analyst ratings are mixed, with a consensus price target below current levels.
16 October 2025
··
Inside Salesforce’s Generative AI Revolution: How Marketing GPT and Einstein GPT Are Reshaping CRM

Salesforce Stock Soars on Bold $60B 2030 Target; Analysts See Big Upside

Salesforce shares rose nearly 5% in pre-market trading Oct. 16, following CEO Marc Benioff’s $60 billion revenue target announcement at Dreamforce. CRM closed at $236.58 on Oct. 15, after hitting a multi-month low of $235.69 earlier in October. The stock remains down about 27–28% year-to-date. Salesforce reported $10.2 billion Q2 revenue and expanded its buyback program to $50 billion.
16 October 2025
··
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Omeros shares soared 150% to $10.42 on Oct. 15 after Novo Nordisk agreed to license its drug zaltenibart (OMS906) for $340 million upfront and up to $2.1 billion in milestones and royalties. Trading volume hit 89.2 million shares, far above average. Omeros reported a Q2 net loss of $25.4 million and $28.7 million in cash as of June 30. Its lead asset narsoplimab remains under FDA and EMA review.
16 October 2025
···
Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Hims & Hers shares jumped 16% on Oct. 15 after launching a menopause care program, trading near $62.80 on Oct. 16, up 7% for the day. The stock has more than doubled in 2025, far outpacing rivals like Teladoc. Regulatory scrutiny from the FDA and FTC triggered brief sell-offs in September. Analyst sentiment remains cautious, with most price targets in the high $30s despite recent gains.
16 October 2025
··
RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

RYOJ shares soared 188% after hours to $6.11 on Oct 15, following a 13% gain in regular trading, despite no company news. The Tokyo-based labor-consulting and health-services firm, which debuted on Nasdaq in August at $4.00, now has a market cap near $21.6 million. Trading volume spiked last week as momentum drove the rally. RYOJ operates 28 clinics and 2 salons in Japan.
16 October 2025
·
1 … 1,265 1,266 1,267 1,268 1,269 … 1,326
Go toTop